Latest Articles

Publication Date
Female chronic pelvic pain: From trauma-informed assessment to evidence-based treatment.

Female chronic pelvic pain (CPP) is a common, complex, multifactorial disorder that can negatively affect sexual functioning and emotional well-being. Effective assessment necessitates a comprehensive patient history and trauma-informed physical …

Published: Jan. 22, 2025, midnight
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - EIN News

Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR EIN News

Published: Jan. 21, 2025, 10:38 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire

Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire

Published: Jan. 21, 2025, 12:38 a.m.
Management of Diaphragmatic Central Tendon Plays an Important Role in the Surgical Treatment of Catamenial Pneumothorax: A Case Report - Cureus

Management of Diaphragmatic Central Tendon Plays an Important Role in the Surgical Treatment of Catamenial Pneumothorax: A Case Report Cureus

Published: Jan. 20, 2025, 9:41 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted

Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted

Published: Jan. 20, 2025, 8:21 a.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews

GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews

Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks

GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks

Published: Jan. 20, 2025, 7:19 a.m.
A cRGD-modified liposome for targeted delivery of artesunate to inhibit angiogenesis in endometriosis.

Currently, hormonal therapy for endometriosis faces challenges in achieving a balance between treatment and preserving the chance of pregnancy. Therefore, the development of non-hormonal therapy holds significant clinical importance. Angiogenesis …

Published: Jan. 20, 2025, midnight
Understanding Deep Endometriosis: From Molecular to Neuropsychiatry Dimension.

Endometriosis is a widely spread disease that affects about 8% of the world's female population. This condition may be described as a spread of endometrial tissue apart from the uterine …

Published: Jan. 20, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!